The facility in Kabul, Afghanistan, is developing into a significant player in the worldwide supply chain for Abacavir Sulphate drug substance. This Afghan manufacturing capacity represents a substantial step onward for the Afghan pharmaceutical industry and provides a special opportunity to miti